BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 2, 2026
Home » Authors » Sharon Kingman

Articles by Sharon Kingman

mRNA Vaccine Protects Higher Animals Against Lethal Flu

Nov. 28, 2012
By Sharon Kingman
LONDON – Vaccines that use synthesized messenger RNA (mRNA) as their building blocks may be able to provide rapid protection against emerging infectious diseases in the future, a new study suggested.
Read More

mRNA Vaccine Protects Higher Animals Against Lethal Flu

Nov. 27, 2012
By Sharon Kingman
LONDON – Vaccines that use synthesized messenger RNA (mRNA) as their building blocks may be able to provide rapid protection against emerging infectious diseases in the future, a new study suggested.
Read More

Caterpillar Fungus Yields Clues to Anti-Inflammatory Strategies

Nov. 21, 2012
By Sharon Kingman
LONDON – A compound isolated from a traditional Chinese medicine has specific anti-inflammatory properties and could offer a way to develop a new class of anti-inflammatory drugs.
Read More

Method Provides Shortcut to Gene Identification: Study

Nov. 14, 2012
By Sharon Kingman
LONDON – A new low-cost technique will allow scientists to easily monitor all the genes and proteins being switched on and off in different cells under different circumstances.
Read More

Strategy to Unlock Potential of Genetic Polymorphisms

Nov. 7, 2012
By Sharon Kingman
LONDON – It will be possible to unravel the causative mechanisms of many diseases that have been the subject of genomewide association studies by carrying out genetic investigations in mice, researchers in Scandinavia suggested.
Read More

Small Molecules Offer Route To Promising New Antimalarials

Oct. 31, 2012
By Sharon Kingman
LONDON – Initial tests of a new strategy aimed at killing the malaria parasite suggested that it may one day provide a fast and effective way of treating that infection.
Read More

Study: Cancer Cell Proteins Join Forces to Achieve Movement

Oct. 24, 2012
By Sharon Kingman
LONDON – A protein that determines how well cells can move and spread could provide a new target for drug designers who want to prevent metastasis of cancer cells.
Read More

Study Pinpoints Inflammatory Gatekeeper for Bowel Disease

Oct. 18, 2012
By Sharon Kingman
LONDON – A better understanding of the molecular and cellular interactions that help to trigger inflammatory bowel disease in mice could one day lead to new ways of treating conditions such as ulcerative colitis and Crohn's disease in humans.
Read More

Study Pinpoints Inflammatory Gatekeeper for Bowel Disease

Oct. 16, 2012
By Sharon Kingman
LONDON – A better understanding of the molecular and cellular interactions that help to trigger inflammatory bowel disease in mice could one day lead to new ways of treating conditions such as ulcerative colitis and Crohn's disease in humans.
Read More

Structure of Cleavage Enzyme Holds Clues to New Treatments

Oct. 10, 2012
By Sharon Kingman
LONDON – The discovery of the structure of an enzyme that helps to regulate levels of proteins in the body could lead to new drugs to treat a range of diseases, from Alzheimer's to cancer and inflammation.
Read More
Previous 1 2 … 9 10 11 12 13 14 15 16 17 … 107 108 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 2, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing